Rights and permissions
About this article
Cite this article
FDA outlines generic substitution policy. Inpharma Wkly. 1128, 5 (1998). https://doi.org/10.2165/00128413-199811280-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811280-00008